Arena Pharmaceuticals Company Profile (NASDAQ:ARNA)

About Arena Pharmaceuticals

Arena Pharmaceuticals logoArena Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that target G protein-coupled receptors (GPCRs). The Company's drug, Lorcaserin, is approved for marketing in the United States and South Korea for the indication of weight management, and is being commercialized under the brand name, BELVIQ. The Company's drug candidates in clinical development include APD334 for autoimmune diseases, ralinepag for vascular diseases and APD371 for pain. APD334 is an orally available modulator of the sphingosine 1-phosphate subtype 1 (S1P1) receptor intended for the treatment of multiple sclerosis, psoriasis, inflammatory bowel diseases and rheumatoid arthritis. The Company's programs under collaboration include nelotanserin for dementia-associated psychosis, temanogrel for thrombotic diseases and an undisclosed orphan GPCR for central nervous system indication(s).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: ARNA
  • CUSIP: 04004710
Key Metrics:
  • Previous Close: $1.77
  • 50 Day Moving Average: $1.64
  • 200 Day Moving Average: $1.72
  • 52-Week Range: $1.30 - $2.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.30
  • P/E Growth: 0.25
  • Market Cap: $425.70M
  • Outstanding Shares: 243,256,000
  • Beta: -0.76
Profitability:
  • Net Margins: -291.35%
  • Return on Equity: -226.09%
  • Return on Assets: -42.15%
Debt:
  • Debt-to-Equity Ratio: 4.69%
  • Current Ratio: 2.56%
  • Quick Ratio: 2.39%
Additional Links:
Companies Related to Arena Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Arena Pharmaceuticals (NASDAQ:ARNA) (?)
Ratings Breakdown: 4 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $3.83 (119.05% upside)

Analysts' Ratings History for Arena Pharmaceuticals (NASDAQ:ARNA)
Show:
DateFirmActionRatingPrice TargetDetails
9/15/2016FBR & CoInitiated CoverageOutperform$6.00View Rating Details
8/13/2016Needham & Company LLCReiterated RatingHoldView Rating Details
8/10/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/8/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details
5/10/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details
3/2/2016Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
3/1/2016Royal Bank Of CanadaReiterated RatingSector Perform$2.00 -> $1.50View Rating Details
10/28/2015WallachBeth CapitalLower Price TargetBuy$6.00 -> $4.00View Rating Details
5/14/2015BMO Capital MarketsReiterated RatingMarket Perform$9.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Arena Pharmaceuticals (NASDAQ:ARNA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2016        
8/8/2016Q216($0.10)($0.11)$10.44 million$9.50 millionViewN/AView Earnings Details
5/9/2016Q116($0.10)($0.09)$9.02 million$9.80 millionViewN/AView Earnings Details
2/29/2016Q415($0.13)($0.13)$8.26 million$7.80 millionViewN/AView Earnings Details
11/10/2015Q315($0.13)($0.11)$8.87 million$9.10 millionViewN/AView Earnings Details
8/5/2015Q215($0.14)($0.11)$10.95 million$9.18 millionViewN/AView Earnings Details
5/11/2015Q115($0.14)($0.10)$10.56 million$12.30 millionViewN/AView Earnings Details
3/2/2015Q414($0.12)($0.15)$10.36 million$9.20 millionViewN/AView Earnings Details
11/3/2014Q314($0.12)($0.05)$10.90 million$8.20 millionViewN/AView Earnings Details
8/1/2014Q2 14($0.11)$0.03$9.81 million$12.80 millionViewN/AView Earnings Details
5/12/2014Q114($0.10)($0.12)$7.98 million$6.80 millionViewN/AView Earnings Details
2/27/2014Q413$0.02($0.11)$7.00 million$6.50 millionViewN/AView Earnings Details
11/7/2013Q313($0.12)($0.08)$5.30 million$3.60 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.15$0.18$57.30 million$68.90 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.11$0.09$50.36 million$2.37 millionViewN/AView Earnings Details
3/4/2013Q4 2012($0.03)($0.10)$21.94 million$1.94 millionViewN/AView Earnings Details
11/6/2012Q312($0.11)($0.07)$3.72 million$1.50 millionViewN/AView Earnings Details
8/9/2012($0.08)($0.12)ViewN/AView Earnings Details
11/9/2011($0.14)($0.16)ViewN/AView Earnings Details
8/9/2011($0.15)($0.16)ViewN/AView Earnings Details
5/10/2011($0.21)($0.35)ViewN/AView Earnings Details
3/11/2011($0.22)($0.23)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Arena Pharmaceuticals (NASDAQ:ARNA)
Current Year EPS Consensus Estimate: $-0.35 EPS
Next Year EPS Consensus Estimate: $-0.33 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.07)($0.07)($0.07)
Q4 20161($0.07)($0.07)($0.07)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Arena Pharmaceuticals (NASDAQ:ARNA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Arena Pharmaceuticals (NASDAQ:ARNA)
Insider Ownership Percentage: 2.14%
Institutional Ownership Percentage: 48.41%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/13/2016Christine Anna WhiteDirectorSell18,728$1.99$37,268.72View SEC Filing  
3/30/2015Randall E WoodsDirectorSell76,268$4.49$342,443.32View SEC Filing  
3/17/2015Steven W SpectorEVPSell70,000$5.00$350,000.00View SEC Filing  
1/8/2015Steven W SpectorEVPSell45,000$6.26$281,700.00View SEC Filing  
1/7/2015William R Shanahan JrSVPSell50,000$5.49$274,500.00View SEC Filing  
7/1/2014Jack LiefCEOSell223,525$5.85$1,307,621.25View SEC Filing  
6/27/2014Donald D BelcherDirectorSell2,473$5.85$14,467.05View SEC Filing  
5/6/2014Donald BelcherDirectorSell4,176$7.00$29,232.00View SEC Filing  
4/22/2014Harry Hixson, Jr.DirectorSell36,900$6.31$232,839.00View SEC Filing  
4/14/2014Tina Susan NovaDirectorSell35,000$6.22$217,700.00View SEC Filing  
4/1/2014Donald BelcherDirectorSell1,905$6.45$12,287.25View SEC Filing  
4/1/2014William Shanahan, Jr.SVPSell60,000$6.37$382,200.00View SEC Filing  
3/4/2014Steven SpectorEVPSell25,000$7.01$175,250.00View SEC Filing  
1/17/2014Jack LiefCEOSell100,000$7.81$781,000.00View SEC Filing  
1/10/2014Dominic BehanEVPSell33,332$6.25$208,325.00View SEC Filing  
9/10/2013Dominic P BehanEVPSell200,000$6.31$1,262,000.00View SEC Filing  
9/5/2013Steven W SpectorEVPSell20,000$6.54$130,800.00View SEC Filing  
5/21/2013Craig Michael AudetSVPSell83,750$8.00$670,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Arena Pharmaceuticals (NASDAQ:ARNA)
DateHeadline
benzinga.com logoWatch These 5 Huge Call Purchases In Thursday Trade - Benzinga (NASDAQ:ARNA)
www.benzinga.com - September 29 at 8:23 AM
News Icon2 Sizzling Hot Biotechnology Stocks: Keryx Biopharmaceuticals Inc ... - The Independent Republic (NASDAQ:ARNA)
theindependentrepublic.com - September 28 at 3:32 PM
News IconActive biotech company shares in the news: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Actinium Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 28 at 3:32 PM
News IconHC Stocks in the Rumor! Keryx Biopharmaceuticals (KERX), Arena ... - share market updates (press release) (NASDAQ:ARNA)
sharemarketupdates.com - September 26 at 3:37 PM
News IconBiotech news that matter for investors: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Tokai Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 26 at 3:37 PM
News IconActive Biotech Stock News: Celgene Corporation (CELG), Arena ... - The Independent Republic (NASDAQ:ARNA)
theindependentrepublic.com - September 24 at 8:53 AM
News IconHC Stocks Zone! Arena Pharmaceuticals, Inc. (ARNA), Opko Health ... - share market updates (press release) (NASDAQ:ARNA)
sharemarketupdates.com - September 24 at 8:53 AM
News IconUnder the Microscope, Zeroing in at Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA)
www.duncanindependent.com - September 22 at 3:34 PM
News IconTrading the Biotech News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Dynavax Technologies Corporation ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 22 at 3:34 PM
News IconBiotech news that matter for investors: CytRx Corporation (NASDAQ ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 21 at 4:29 PM
News IconHC Stocks in the Rumor! Arena Pharmaceuticals, Inc. (ARNA), CVS Health Corp (NYSE:CVS) - share market updates (press release) (NASDAQ:ARNA)
sharemarketupdates.com - September 21 at 8:32 AM
News IconPenny Stock Investors Take an Interest in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA)
www.duncanindependent.com - September 20 at 3:35 PM
News IconTime To Put On The Watch List? - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Arena Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 20 at 3:35 PM
News IconBiotech Stocks To Put On Your Watch List: Concordia International Corp. (NASDAQ:CXRX), Arena Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 19 at 4:31 PM
capitalcube.com logoArena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : September 19, 2016 (NASDAQ:ARNA)
www.capitalcube.com - September 19 at 4:31 PM
capitalcube.com logoArena Pharmaceuticals, Inc. – Value Analysis (NASDAQ:ARNA) : September 19, 2016 (NASDAQ:ARNA)
www.capitalcube.com - September 19 at 4:31 PM
investopedia.com logoArena Launches Drug Discovery Incubator (ARNA) (NASDAQ:ARNA)
www.investopedia.com - September 19 at 4:31 PM
investopedia.com logoArena Launches Drug Discovery Incubator (ARNA) (NASDAQ:ARNA)
www.investopedia.com - September 19 at 4:31 PM
News IconDiverse Stocks in Expert's Opinion: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Provectus Biopharmaceuticals, Inc ... - Street Wise Report (press release) (blog) (NASDAQ:ARNA)
streetwisereport.com - September 19 at 8:20 AM
News IconHC Stocks Overview! CVS Health Corp (CVS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - share market updates (press release) (NASDAQ:ARNA)
sharemarketupdates.com - September 19 at 8:20 AM
News IconArena Pharmaceuticals, Inc.'s (ARNA): Market Mover - Hot Stocks Point (NASDAQ:ARNA)
www.hotstockspoint.com - September 19 at 8:20 AM
News IconArena Pharmaceuticals, Inc.'s (ARNA): Worth Watching Stock - Hot Stocks Point (NASDAQ:ARNA)
www.hotstockspoint.com - September 16 at 3:34 PM
News IconGrowth Analysis of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Newburg Press (NASDAQ:ARNA)
newburghpress.com - September 16 at 12:16 PM
News IconHC Stocks Midpoint! Arena Pharmaceuticals, Inc. (ARNA), CVS Health Corp (NYSE:CVS) - share market updates (press release) (NASDAQ:ARNA)
sharemarketupdates.com - September 16 at 12:16 PM
capitalcube.com logoArena Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ARNA-US : September 16, 2016 (NASDAQ:ARNA)
www.capitalcube.com - September 16 at 12:16 PM
fidaily.com logoFBR Capital Initiates Coverage on Arena Pharmaceuticals, Inc. (ARNA) With An Initial Rating Of “Outperform” (NASDAQ:ARNA)
www.fidaily.com - September 15 at 12:30 PM
finance.yahoo.com logoCoverage initiated on Arena Pharm by FBR & Co. (NASDAQ:ARNA)
finance.yahoo.com - September 15 at 12:30 PM
News IconAnalysts Valuations For Two Stocks: KB Home (NYSE:KBH), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 14 at 8:50 PM
News IconArena Pharmaceuticals, Inc. (NASDAQ:ARNA) Earnings Preview ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 14 at 7:53 AM
capitalcube.com logoETF’s with exposure to Arena Pharmaceuticals, Inc. : September 12, 2016 (NASDAQ:ARNA)
www.capitalcube.com - September 12 at 3:34 PM
insidermonkey.com logoHow Hedge Funds Were Passing Around Marijuana Stocks in Q2 (NASDAQ:ARNA)
www.insidermonkey.com - September 12 at 3:34 PM
News IconTime To Put On The Watch List? – Opko Health, Inc. (NASDAQ:OPK ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 10 at 8:20 AM
News IconNews review of 2 biotech stocks: Radius Health, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 8 at 3:33 PM
seekingalpha.com logoArena Co-Founder Steps Down To Run Research Company Contracting With Arena (NASDAQ:ARNA)
seekingalpha.com - September 7 at 8:43 PM
News IconAnalysts Valuations For Two Stocks: Genworth Financial Inc (NYSE:GNW), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 7 at 12:39 PM
News IconBiotechnology Stocks in Focus: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD) - Post Registrar (NASDAQ:ARNA)
postregistrar.com - September 7 at 12:39 PM
News IconHot Biotech Stocks Recap: Arena Pharmaceuticals (NASDAQ:ARNA), PDL BioPharma (NASDAQ:PDLI) - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 6 at 3:37 PM
News IconStock Struggling for the Quarter: Arena Pharmaceuticals, Inc ... - Post News (NASDAQ:ARNA)
www.kentuckypostnews.com - September 4 at 3:30 PM
News IconStocks Gainers/Losers Roundup- Teva Pharmaceutical Industries (TEVA), Arena Pharmaceuticals (ARNA), Tribune ... - Seneca Globe (NASDAQ:ARNA)
www.senecaglobe.com - September 2 at 3:36 PM
News IconShares of Cypress Semiconductor Corporation (NASDAQ:CY) & Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stocks ... - Money News (NASDAQ:ARNA)
www.newsismoney.com - September 2 at 3:36 PM
streetinsider.com logoArena Pharma (ARNA) Forms Drug Discovery Incubator 'Beacon Discovery' - StreetInsider.com (NASDAQ:ARNA)
www.streetinsider.com - September 2 at 3:36 PM
News IconIntraday Active Biotech Stocks News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Amgen Inc. (NASDAQ:AMGN) - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - September 2 at 3:36 PM
smarteranalyst.com logoStock Update (NASDAQ:ARNA): Arena Pharmaceuticals, Inc. Announces Formation of Beacon Discovery - Smarter Analyst (NASDAQ:ARNA)
www.smarteranalyst.com - September 2 at 8:15 AM
finance.yahoo.com logo4:31 pm Arena Pharm announces formation of Beacon Discovery, an independent, privately-held drug discovery incubator (NASDAQ:ARNA)
finance.yahoo.com - September 2 at 8:15 AM
publicnow.com logoArena Pharmaceutics Announces Formation of Beacon Discovery (NASDAQ:ARNA)
www.publicnow.com - September 2 at 8:15 AM
biz.yahoo.com logoARENA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:ARNA)
biz.yahoo.com - September 2 at 8:15 AM
News IconTaking a Serious Look at Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA)
www.duncanindependent.com - August 31 at 3:34 PM
News IconZeroing Our Focus on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) - Duncan Research (NASDAQ:ARNA)
www.duncanindependent.com - August 30 at 3:34 PM
News IconActive biotech company shares in the news: Raptor Pharmaceuticals ... - The Voice Registrar (NASDAQ:ARNA)
voiceregistrar.com - August 30 at 3:34 PM
uk.finance.yahoo.com logoWith Revenues Climbing, Innovus Pharma Adds Robert E. Hoffman as its Chief Financial Officer (NASDAQ:ARNA)
uk.finance.yahoo.com - August 29 at 8:21 AM

Social

Arena Pharmaceuticals (NASDAQ:ARNA) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff